Merck & Co (MRK)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Kenneth C. Frazier
Employees:
69,000
2000 GALLOPING HILL ROAD, KENILWORTH, NJ 07033
908-740-4000

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines, which it sells to veterinarians, distributors and animal producers. The Alliances segment includes revenue from the company relationship with AstraZeneca LP. The Healthcare Services segment provides services and solutions that focus on engagement, health analytics and clinical services to improve the value of care delivered to patients. The company was founded in 1970 and is headquartered in Kenilworth, NJ.

Data derived from most recent annual or quarterly report
Market Cap 206.712 Billion Shares Outstanding2.531 Billion Avg 30-day Volume 19.959 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 84.56 / 15.05 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from MRK instead.

View recent insider trading info

Funds Holding MRK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MRK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WENDELL PETER C

  • Director
109,900 2021-09-30 5

GLOCER THOMAS H

  • Director
84,222 2021-09-30 3

COE MARY ELLEN

  • Director
12,334 2021-09-30 5

SEIDMAN CHRISTINE E

  • Director
6,940 2021-09-30 5

DOWNING CRISTAL N CHIEF COMM. & PUBLIC AFRS OFCR

  • Officer
0 2021-08-16 1

KLOBUCHAR MICHAEL A EVP - CHIEF STRATEGY OFFICER

  • Officer
12,510 2021-07-05 1

RUSSO PATRICIA F

  • Director
55,542 2021-05-28 1

LAVIZZO-MOUREY RISA J

  • Director
6,193 2021-05-28 1

BRUN LESLIE A

  • Director
51,667 2021-05-28 1

CRAIG PAMELA J.

  • Director
21,237 2021-05-28 1

THULIN INGE G

  • Director
13,393 2021-05-28 1

WARDEN KATHY J

  • Director
5,810 2021-05-28 1

ROTHMAN PAUL

  • Director
19,622 2021-05-28 1

MAYO STEPHEN

  • Director
2,855 2021-05-28 3

CLYBURN FRANK EVP & PRES ? HUMAN HEALTH

  • Officer
115,424 2021-05-10 4

FRAZIER KENNETH C CHAIRMAN & CEO

  • Officer
  • Director
920,156 2021-05-04 4

MIZELL STEVEN EVP, CHIEF HR OFFICER

  • Officer
87,467 2021-05-04 3

DAVIS ROBERT M PRESIDENT

  • Officer
499,330 2021-05-04 2

DELUCA RICHARD R. EVP&PRES, MERCK ANIMAL HEALLTH

  • Officer
198,819 2021-05-04 2

KARACHUN RITA A SR. VP FINCE-GLOBAL CONTROLLER

  • Officer
59,992 2021-05-04 3

GERBERDING JULIE L. EVP STRAT COMM, GI PUB POLICY

  • Officer
78,958 2021-05-04 2

CHATTOPADHYAY SANAT EXE V-P & PRES. MMD

  • Officer
178,859 2021-05-04 2

ZACHARY JENNIFER EVP, GENERAL COUNSEL

  • Officer
116,794 2021-05-04 2

WILLIAMS DAVID MICHAEL EVP,CHIEF INFO&DIGITAL OFFICER

  • Officer
39,192 2021-05-04 3

LI DEAN Y EXECUTIVE VP & PRESIDENT, MRL

  • Officer
104,147 2021-05-04 4

LECOINTE-CEPHAS LISA SVP CHIEF ETHICS & COM OFFICER

  • Officer
23,110 2021-05-04 3

LITCHFIELD CAROLINE EVP & CFO

  • Officer
87,088 2021-05-04 3

NALLY MICHAEL EVP, CHIEF MARKETING OFFICER

  • Officer
21,390 2021-02-26 2

FLEMING MICHAEL SVP CHIEF ETHICS & COM OFFICER

  • Officer
10,283 2021-02-26 1

CECH THOMAS R

  • Director
100 2020-05-29 0

WEEKS WENDELL P

  • Director
100 2020-05-07 0

PERLMUTTER ROGER M EXE V-P & PRES, MRL

  • Officer
215,060 2020-05-01 0

LAZARUS ROCHELLE B

  • Director
6,351 2020-03-31 0

SCHOLEFIELD JAMES H EVP,CHIEF INFO&DIGITAL OFFICER

  • Officer
7,142 2019-10-30 0

NOSEWORTHY JOHN H

  • Director
100 2019-03-29 0

SCHECHTER ADAM H EVP & PRES-GLOBAL HUMAN HEALTH

  • Officer
55,406 2018-11-01 0

WATSON ASHLEY SVP CHIEF ETHICS & COM OFFICER

  • Officer
9,962 2018-10-31 0

THOMPSON CRAIG B.

  • Director
3,352 2018-05-25 0

GRADDICK WEIR MIRIAN M EXE V-P, HR

  • Officer
80,433 2018-05-04 0

HOLSTON MICHAEL J EVP, GENERAL COUNSEL

  • Officer
69,786 2018-02-27 0

REPRESAS CARLOS E

  • Director
11,500 2017-05-26 0

KIDDER C ROBERT

  • Director
10,339 2017-05-12 0

AMBROSE ADELE D SR.V-P & CHIEF COMUNS OFFICER

  • Officer
22,708 2017-05-05 0

GOLESTANI CLARK EVP & CHIEF INFO OFFICER

  • Officer
19,943 2016-08-10 0

ROSENBLATT MICHAEL EXEC V-P & CHIEF MED OFFICER

  • Officer
41,473 2016-05-10 0

HARRISON WILLIAM B JR

  • Director
16,400 2016-04-13 0

DEESE WILLIE A EXE V-P & PRES. MMD

  • Officer
134,478 2016-02-22 0

KUHLIK BRUCE N EXE V-P & GEN COUNSEL

  • Officer
150,432 2015-05-01 0

HELLER BRIDGETTE P EXE.VP & PRES.CON.HLTH.CARE

  • Officer
35,474 2014-05-09 0

KELLOGG PETER N EXE V-P & CFO

  • Officer
149,554 2014-02-24 0

CANAN JOHN SR.V-P FINC-GLOBAL CONTROLLER

  • Officer
16,956 2014-02-24 0

DO CUONG V EVP & CHIEF STRATEGY OFFICER

  • Officer
0 2013-05-06 0

KIM PETER S EXE V-P & PRES, MRL

  • Officer
190,957 2013-02-25 0

BOWLES RICHARD S III EXE VP&CHIEF ETHICS & COMPLOFF

  • Officer
77,545 2012-05-10 0

SCALET J CHRIS EXE V-P GLOBAL SRVS & CIO

  • Officer
83,041 2012-05-02 0

TATLOCK ANNE M

  • Director
1,114 2012-03-30 0

KELLEY WILLAM N

  • Director
4,311 2012-03-30 0

GOLDSTONE STEVEN F

  • Director
1,000 2012-03-30 0

KOHAN RAUL E EXE VICE PRESIDENT

  • Officer
No longer subject to file 2011-12-31 0

SHENK THOMAS E

  • Director
1,000 2011-05-27 0

JACOBSON HARRY R

  • Director
4,034 2011-05-27 0

CLARK RICHARD T CHAIRMAN

  • Officer
  • Director
257,538 2011-02-28 0

TURNER MERVYN CHIEF STRATEGY OFFICER

  • Officer
27,969 2011-02-28 0

BARSHAY STANLEY F EXVP&PRESCONSHLTHCARE

  • Officer
72,765 2010-03-05 0

STAHL JACK L

  • Director
No longer subject to file 2009-11-03 0

VAN OORDT ROBERT FW

  • Director
No longer subject to file 2009-11-03 0

HASSAN FRED CHAIRMAN AND CEO

  • Officer
  • Director
No longer subject to file 2009-11-03 0

COX CARRIE SMITH EXECUTIVE VICE PRESIDENT

  • Officer
No longer subject to file 2009-11-03 0

SABATINO THOMAS J JR EXECUTIVE VICE PRESIDENT

  • Officer
No longer subject to file 2009-11-03 0

THIER SAMUEL O MD

  • Director
No longer subject to file 2009-11-03 0

KOEHLER STEVEN H VICE PRESIDENT AND CONTROLLER

  • Officer
No longer subject to file 2009-11-03 0

TURNER KATHRYN C

  • Director
No longer subject to file 2009-11-03 0

COLBERT CELIA A SR. V-P, SEC.& AST.GEN.COUNSEL

  • Officer
No longer subject to file 2009-11-03 0

WEINBACH ARTHUR F

  • Director
No longer subject to file 2009-11-03 0

PEREZ ANTONIO M

  • Director
No longer subject to file 2009-11-03 0

MCGRATH EUGENE R

  • Director
No longer subject to file 2009-11-03 0

CHEELEY C RON SENIOR VICE PRESIDENT

  • Officer
No longer subject to file 2009-11-03 0

SAUNDERS BRENT L SENIOR VICE PRESIDENT

  • Officer
No longer subject to file 2009-11-03 0

BERTOLINI ROBERT J EXECUTIVE VICE PRESIDENT

  • Officer
No longer subject to file 2009-11-03 0

COLLIGAN THOMAS J

  • Director
No longer subject to file 2009-11-03 0

KOESTLER THOMAS P EXECUTIVE VICE PRESIDENT

  • Officer
No longer subject to file 2009-11-03 0

OSCHMANN STEFAN PRESIDENT, EMEA & CANADA

  • Officer
No longer subject to file 2009-11-03 0

MCDONOUGH MARK E VICE PRESIDENT AND TREASURER

  • Officer
No longer subject to file 2009-11-03 0

QUEISSER LORI A. SENIOR VICE PRESIDENT

  • Officer
No longer subject to file 2009-11-03 0

BECHERER HANS W

  • Director
No longer subject to file 2009-10-14 0

MUNDY CARL E JR

  • Director
No longer subject to file 2009-10-14 0

MCGLYNN MARGARET G PRESIDENT, MV & ID

  • Officer
64,673 2009-04-24 0

LEDER PHILIP

  • Director
No longer subject to file 2008-12-01 0

COLE JOHNNETTA B

  • Director
460 2008-04-30 0

ANSTICE DAVID W EXEC.V-P, STRATEGY INITIATIVES

  • Officer
156,917 2008-03-31 0

YARNO WENDY L CHIEF MARKETING OFFICER

  • Officer
36,144 2008-02-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SEIDMAN CHRISTINE E - Director

2021-10-01 11:33:10 -0400 2021-09-30 A 216 $75.11 a 6,840 direct

GLOCER THOMAS H - Director

2021-10-01 11:35:17 -0400 2021-09-30 A 117 $75.11 a 79,122 direct

COE MARY ELLEN - Director

2021-10-01 11:31:22 -0400 2021-09-30 A 433 $75.11 a 12,324 direct

WENDELL PETER C - Director

2021-10-01 11:38:03 -0400 2021-09-30 A 399 $75.11 a 108,900 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MERCK & CO INC MRK 2021-10-26 19:15:03 UTC -0.1966 0.2666 0
MERCK & CO INC MRK 2021-10-26 18:45:03 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-26 18:15:03 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-26 17:45:03 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-26 17:15:03 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-26 16:45:04 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-26 16:15:03 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-26 15:45:03 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-26 15:15:03 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-26 14:45:03 UTC -0.1952 0.2652 0
MERCK & CO INC MRK 2021-10-26 14:15:05 UTC -0.1952 0.2652 0
MERCK & CO INC MRK 2021-10-26 13:45:03 UTC -0.1952 0.2652 0
MERCK & CO INC MRK 2021-10-26 13:15:03 UTC -0.1952 0.2652 0
MERCK & CO INC MRK 2021-10-26 12:45:03 UTC -0.1952 0.2652 0
MERCK & CO INC MRK 2021-10-25 22:15:03 UTC -0.1952 0.2652 0
MERCK & CO INC MRK 2021-10-25 21:45:03 UTC -0.1907 0.2607 0
MERCK & CO INC MRK 2021-10-25 21:15:03 UTC -0.1907 0.2607 0
MERCK & CO INC MRK 2021-10-25 20:45:03 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-25 20:15:03 UTC -0.18 0.25 0
MERCK & CO INC MRK 2021-10-25 19:45:04 UTC -0.18 0.25 0

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund MRK -296.0 shares, $-24212.8 2020-12-31 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund MRK -1167.0 shares, $-95460.6 2020-12-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF MRK -2503.0 shares, $-194658.31 2021-06-30 N-PORT
INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund MRK -891.0 shares, $-69293.07 2021-06-30 N-PORT

Elevate your investments